shopping cart
nothing in cart
browse by subject
new releases
best sellers
sale books
browse by author
browse by publisher
about us
upcoming events
Oct 14th - 66th annual meeting of the American Academy of Child & Adolescent Psychiatry, Chicago, IL [AACAP]
Oct 14th - SPECIAL EVENT – Infant Research and Adult Treatment: A Study Evening [tps&i - Toronto Psychoanalytic Society & Institute]
Oct 16th - 8 Week Mindful Self-Compassion Program [The Centre for MindBody Health]
Oct 16th - The Leadership Edge: Empower and engage employees for maximum performance [SickKids CCMH Learning Institute]
Oct 16th - Management Certificate: Leadership training specifically designed for health and human service professionals [SickKids CCMH Learning Institute]
schools agencies and other institutional orders (click here)
Stockley's Drug Interactions: A Source Book of Interactions Their Mechanisms Clinical Importance and Management, 11th edition
Preston, Claire L.
Pharmaceutical Press / Hardcover / 2016-03-01 / 0857112708
Medicine: Pharmacy
reg price: $456.95 our price: $ 434.10 (may be subject to change)
Not in stock - available within 6 weeks.

Stockley's Drug Interactions, edited by Claire L Preston, remains the world's most comprehensive and authoritative international reference book on drug interactions. Based upon thousands of published papers and reports this eleventh edition:

Covers interactions between therapeutic drugs, proprietary medicines, herbal medicines, foods, drinks, and drugs of abuse
Contains in-depth yet concise monographs in an easy-to-read format
Provides comprehensive details of the clinical evidence for the interactions under discussion, an assessment of their clinical importance, and clear guidance on managing the interaction in practice
Has a brief summary of the interaction in each monograph—perfect for the busy healthcare professional
Is fully referenced throughout
Contains almost 4500 monographs
Is global in coverage—inclusion of drugs used worldwide

New in the 11th edition:
Over 350 new monographs added
Many existing monographs have been reviewed, revalidated, and updated
A comprehensive update and restructure of the chapter on Antidiabetic drugs, in-line with published literature
Addition of new advice regarding the concurrent use of aliskiren, ACE inhibitors, and angiotensin-II receptor antagonists
An updated list of drugs that have a risk of prolonging the QT interval
The addition of new drugs, including apixaban, apremilast, dolutegravir, lomitapide, mirabegron, the NS5A inhibitors (daclatasvir, ledipasvir, ombitasvir), the NS5B inhibitors (dasabuvir, sofosbuvir), the sodium-glucose co-transporter-2 inhibitors (canagliflozin, dapagliflozin, empagliflozin), and telavancin

Caversham Booksellers
98 Harbord St, Toronto, ON M5S 1G6 Canada
(click for map and directions)
All prices in $cdn
Copyright 2019

Phone toll-free (800) 361-6120
Tel (416) 944-0962 | Fax (416) 944-0963
Hours: 9-6 M-W / 9-7 Th-F / 10-6 Sat / 12-5 Sun EST

Click here to read previous issues.
other lists
Medicine: Pharmacy